Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority


Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.


BY CHRISTINA JEWETT AND PAM BELLUCK | NYTimes Health | Disclosure

Comments